Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Farmers Insurance
Chinese Patent Office
Federal Trade Commission

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,524,834

« Back to Dashboard

Which drugs does patent 7,524,834 protect, and when does it expire?

Patent 7,524,834 protects PULMICORT RESPULES and is included in one NDA. There have been two Paragraph IV challenges on Pulmicort Respules.

Protection for PULMICORT RESPULES has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 7,524,834

Title:Sterile powders, formulations, and methods for producing the same
Abstract:The invention provides sterile glucocorticosteroids and sterile formulations containing glucocorticosteroid and use thereof in the treatment of an allergic and/or inflammatory condition of the nose or the lungs.
Inventor(s): Karlsson; Ann-Kristin (Staffanstorp, SE), Larrivee-Elkins; Cheryl (Framingham, MA), Molin; Ove (Huddinge, SE)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:09/993,669
Patent Claim Types:
see list of patent claims
Composition; Use; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Astrazeneca Pharms
SUSPENSION;INHALATION020929-001Aug 8, 2000ANRXYesNo► Subscribe► SubscribeY
Astrazeneca Pharms
SUSPENSION;INHALATION020929-002Aug 8, 2000ANRXYesNo► Subscribe► SubscribeY
Astrazeneca Pharms
SUSPENSION;INHALATION020929-003Aug 8, 2000ANRXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,524,834

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9704186Nov 14, 1997

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus